Profound Medical Corp.

NASDAQ:PROF

Medical - Devices

Healthcare
$6.59 +4.11%

+$0.27 today

Market cap
$241.37M
Beta
0.52
P/E (TTM)
-6.3
EPS (TTM)
-$1.07
52W Low $3.76High $8.95

Volume 0.10M

Average 0.12M

Income Statement

Follow revenue through to earnings.

Revenue

$16.38M

FY 2025 · Annual

+61.1% YoY

Operating Income

-$41.98M

FY 2025 · Annual

Net Income

-$43.32M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue6.87M6.68M7.2M10.17M16.38M
Cost of Revenue3.92M3.66M2.82M3.47M4.79M
Gross Profit2.95M3.02M4.38M6.7M11.59M
Gross Margin43.0%45.2%60.9%65.9%70.8%
Research & Development15.28M14.69M14.38M16.15M20.96M
Selling, General & Admin17.97M17.93M18.62M22.02M32.61M
Operating Expenses33.24M35.15M33M38.17M53.57M
Depreciation & Amortization1.88M1.6M1.15M891.06K569.8K
EBITDA(28.65M)(26.6M)(26.78M)(25.59M)(41.41M)
EBITDA Margin-416.8%-398.2%-372.0%-251.7%-252.8%
Operating Income(30.29M)(32.13M)(28.62M)(31.47M)(41.98M)
Operating Margin-440.7%-480.9%-397.5%-309.6%-256.3%
Interest Income203.2K1.05M1.64M1.37M1.09M
Interest Expense66.41K167.11K770K00
Other Income / Expenses(303K)3.74M(81K)4.99M(1.08M)
Income Before Tax(30.59M)(28.38M)(28.7M)(26.48M)(43.06M)
Pre-Tax Margin-445.1%-424.8%-398.6%-260.5%-262.9%
Income Tax Expense105K287K(128K)(1.9K)256.41K
Net Income(30.7M)(28.67M)(28.57M)(26.48M)(43.32M)
Net Margin-446.7%-429.1%-396.8%-260.4%-264.4%
EPS (Basic)(1.50)(1.38)(1.35)(1.07)(1.43)
EPS (Diluted)(1.50)(1.38)(1.35)(1.07)(1.43)
Weighted Avg Shares20.46M20.83M21.18M24.77M30.23M
Weighted Avg Shares (Diluted)20.47M20.83M21.18M24.77M30.23M

PROF Earnings Waterfall · TTM

NASDAQ:PROF · Revenue to Net Income

Key Ratios

EPS$-1.25
Gross Margin71.5%
Net Margin-282.4%
P/E Ratio-5.8
P/S Ratio47.8

Analysis

$18.9M of revenue converted into -$39.2M of net income for the selected period. Gross margin is 71.5% and net margin is -282.4%, showing how much revenue survives after costs and taxes. EPS is $-1.25, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportNov 3, 2026

How much revenue does PROF generate?

Profound Medical Corp. (PROF) reported $16.38M of revenue in fiscal 2025.

Is PROF profitable?

Profound Medical Corp. (PROF) reported -$43.32M of net income, with a net margin of -264.4%.